The lawsuit names L'Oréal, SoftSheen-Carson, Strength of Nature, and other manufacturers. Black women were targeted by these brands and used the products at 2-3x the rate of other groups. We never sell your information.
A 2022 NIH-funded Sister Study found that women who used chemical hair relaxers more than four times a year had nearly double the rate of uterine cancer. The harm fell disproportionately on Black women — not by accident. Manufacturers marketed these products to Black women specifically, knowing the chemical composition. The MDL 3060 is consolidated in N.D. Ill. before Judge Rowland. Bellwether trials begin in 2026.
The science is specific. The NIH-funded Sister Study followed 33,497 U.S. women for over a decade. Women who used chemical straighteners more than four times in the prior year developed uterine cancer at about 2.5 times the rate of women who did not: 4.05% by age 70 versus 1.64% (Chang et al., Journal of the National Cancer Institute, 2022).
The exposure was not random. Relaxers were marketed to Black women for decades and contained phthalates, parabens, and formaldehyde-releasing preservatives, all endocrine disruptors tied to hormone-driven cancers. The MDL 3060 consolidates claims against L'Oréal, SoftSheen-Carson, Strength of Nature, Namaste Laboratories, Dabur, and Revlon.
Three peer-reviewed findings and one federal court consolidation underpin these claims:
Public docket activity in the Northern District of Illinois.
These are the diagnoses most commonly accepted into the intake at MDL-experienced firms. If you have one of these and used chemical relaxers, the eligibility check above is the right next step.
The most common diagnosis named in MDL 3060. Treatment usually involves hysterectomy, often with chemotherapy or radiation depending on stage. The cancer originates in the lining of the uterus.
Tied to relaxer use: The 2022 NIH Sister Study found women using chemical straighteners 4+ times a year had about 2.5x the uterine cancer rate of non-users (4.05% versus 1.64% by age 70).
A higher-mortality cancer that often presents late. Treatment typically involves surgery (oophorectomy and hysterectomy) and chemotherapy. Several Sister Study follow-up analyses found elevated risk in frequent relaxer users.
Tied to relaxer use: Frequent permanent dye and chemical straightener use was tied to higher ovarian and breast cancer risk in the same cohort (Eberle et al., 2019).
Closely related to uterine cancer (most uterine cancers are endometrial). Often treated as the same claim category in MDL 3060 master pleadings.
Tied to relaxer use: Same mechanism as uterine cancer: hormone-driven growth in the uterine lining, with relaxer-associated endocrine disruptors as the suspected pathway.
Non-cancerous tumors of the uterus, but often severe enough to require myomectomy or hysterectomy. A separate liability track in the MDL for plaintiffs whose surgery is documented.
Tied to relaxer use: The Boston University Black Women's Health Study (Wise et al., 2012) found relaxer use associated with higher fibroid incidence.
Accepted by some firms in the MDL, less consistently than the uterine/ovarian/endometrial cluster. Whether your case fits depends on the specific firm and the diagnosis context.
Tied to relaxer use: Eberle et al. (International Journal of Cancer, 2019) found elevated breast cancer risk with frequent permanent dye and straightener use, particularly in Black women.
These are the brand-name products most frequently listed in MDL 3060 master complaints, grouped by the manufacturer that sold them. If you used a chemical hair straightening product not listed here, the eligibility check still applies. The MDL covers the product category, not a specific list.
The largest US relaxer brand portfolio by volume. Acquired by L'Oréal 1998 to 2000.
L'Oréal is named directly as parent and through Mizani's salon distribution channel.
Just for Me is heavily named because of pediatric exposure: children as young as 4 to 6 years old were heavy users.
Marketed as a gentler, oil-based formulation; chemical relaxer claims still apply.
Primarily a salon-channel manufacturer.
Revlon's 2022 bankruptcy materially affects recovery against the Revlon entity. Crème of Nature's current ownership matters for the named-defendant analysis.
Receipts and product photos are helpful but not required. Most plaintiffs document use through a sworn declaration covering brand, frequency, year range, and salon or retail source.
MDL 3060 names the manufacturers as defendants. Several have been acquired or restructured; the relevant entities for purposes of recovery are below.
World's largest cosmetics company (about €38B in global revenue). Owns SoftSheen-Carson and the Mizani professional brand. Named as parent for the SoftSheen-Carson portfolio and directly through Mizani.
Named brands: Dark and Lovely, Optimum Care, Mizani, Healthy-Gloss 5
Historic Black hair care brand built from the SoftSheen and Carson Products mergers. The dominant US relaxer brand portfolio. Acquired by L'Oréal through a two-stage purchase in 1998 to 2000.
Major US ethnic hair care manufacturer acquired by India's Godrej conglomerate. Heavily named because of the children's relaxer line (Just for Me) and the breadth of its African American consumer brands.
Named brands: Just for Me, Africa's Best, Motions, TCB Naturals, African Pride
Indian-owned manufacturer of the ORS Olive Oil portfolio. Marketed its products as gentler oil-based alternatives, but the chemical relaxer formulations face the same claims as competitors.
Named brands: ORS Olive Oil, Olive Oil Girls
Filed Chapter 11 bankruptcy in June 2022 and emerged in 2023. Recovery against the Revlon entity is limited by the bankruptcy reorganization; some brands (such as Crème of Nature) were spun off, which changes which corporate parent is on the hook.
Named brands: Realistic, formerly Crème of Nature
The 60-second eligibility check above tells you if your situation fits the criteria the MDL law firms are intaking. Free, confidential, no obligation.
These are pre-bellwether industry projections from plaintiffs' counsel and observers tracking MDL 3060. They are not court-ordered amounts. The actual settlement schedule will be set by the first bellwether outcomes (anticipated late 2026 or 2027) and the master settlement negotiations that typically follow.
| Diagnosis or claim type | Projected payout range | What drives the tier |
|---|---|---|
| Wrongful death (covered cancer) | $1,000,000 to $1,500,000+ | Highest tier. Family of a plaintiff who died of a covered cancer (most commonly uterine or ovarian). Subject to wrongful-death SOL rules in your state. |
| Late-stage uterine or ovarian cancer (Stage III to IV) | $500,000 to $1,000,000 | Severe diagnosis with extensive treatment (surgery + chemotherapy + radiation). Documented stage and treatment burden drive this tier. |
| Uterine or endometrial cancer requiring hysterectomy | $300,000 to $500,000 | Most common Tier 2 profile in the MDL. Hysterectomy plus follow-up treatment with no major recurrence. |
| Ovarian cancer (early stage) | $200,000 to $500,000 | Higher base than early-stage uterine because of ovarian cancer's higher long-term mortality risk. |
| Uterine or endometrial cancer (early stage, treatable) | $100,000 to $300,000 | Documented diagnosis with successful surgical or hormonal treatment and no extensive systemic therapy. |
| Uterine fibroids requiring surgery | $50,000 to $150,000 | Non-cancerous, but documented myomectomy or hysterectomy is required. Stand-alone fibroid claims are a separate liability track and generally settle lower than the cancer claims. |
These are projections, not guarantees. Your attorney will give you a case-specific projection once your medical records and product-use history are reviewed.
Four steps. You do almost none of the work after step 1.
Three questions confirm you fit the basic class profile: relaxer use, diagnosis, and current attorney status. No payment, no commitment.
About 60 seconds.An attorney from the network reviews your answers and reaches out for a deeper conversation. They confirm whether your specific situation fits their intake criteria.
1 to 2 business days.If accepted, the attorney's intake team gathers your medical records, pathology reports, and treatment history. You sign a HIPAA release; the rest is administrative work the firm handles.
3 to 6 weeks for record collection.Once records are complete, your case is filed in the MDL. From here, your attorney handles all litigation activity (discovery, depositions, settlement negotiation) until your case resolves. You can withdraw at any point before signing the final representation agreement.
Filing happens within 30 days of records being complete.Every state has a statute of limitations (SOL) that sets a hard deadline for filing. Once the clock runs out for your situation, the right to file is gone permanently. The clock varies by state and depends on when you were diagnosed.
If you are unsure whether your case is still within the window, file the eligibility check now. The attorney review is free and the SOL question is one of the first things they evaluate. Missing the SOL is permanent.
claimscout is not a law firm. We connect you with attorneys from a vetted network of firms that handle MDL 3060 cases as a core practice area.
claimscout is a referral service. We do not provide legal advice, do not represent you in court, and are not a substitute for an attorney-client relationship. Sponsored attorney advertising. Past results do not guarantee future outcomes.
The MDL law firms in this case know the documents. They know what the manufacturers knew and when. Your job is not to prove the science — your job is to confirm whether you used these products and were diagnosed.
Real ads, scraped this morning from Meta's public Ad Library. If they are paying to find you, your claim has cash value. We let you pick which firm you want to work with, or skip them entirely and file directly.
🚨 Free Claim Review 🚨 WWW.TALCCLAIMSDIRECT.COM TAKE THE FIRST STEP Deadline Approaching Learn More
Chemical Hair Relaxer Lawsuit: Seek Justice Recent studies have linked long-term exposure to the chemicals in hair relaxers to an elevated risk of uterine cancer, breast cancer, and other serious medical conditions....
Is your hair relaxer hiding dangerous chemicals? Learn the risks & find out if you’re eligible for legal help. ⚠️💡
Most chemical relaxers marketed in the U.S. since the 1990s are named or covered. The most commonly listed brands include Dark and Lovely, Just for Me, Africa's Best, ORS Olive Oil, Optimum Care, Motions, Mizani, Affirm, and Crème of Nature. If you used any chemical hair straightening product four or more times a year for at least a year, the eligibility check is the right next step.
The primary claims are uterine cancer (endometrial carcinoma), ovarian cancer, endometrial cancer, and uterine fibroids requiring surgery. Some firms also accept breast cancer claims based on the 2019 Eberle study.
Yes, and it usually strengthens the case. Pediatric exposure through children's relaxer lines (Just for Me, Olive Oil Girls, Beautiful Beginnings) is a major liability theory in MDL 3060 because of the longer cumulative exposure.
Yes. Wrongful death claims are part of MDL 3060. SOL rules for wrongful death typically run from the date of death rather than the date of diagnosis. The attorney will walk you through the documentation needed (death certificate, pathology, product-use history).
Realistically, 2 to 4 years from filing. Bellwether trials in MDL 3060 are anticipated in late 2026 or 2027, and master settlement negotiations typically follow the first bellwether outcomes. Individual cases may settle on different timelines depending on tier.
We connect you. The eligibility check above routes qualified cases to an MDL-experienced attorney from the network. You can accept or decline that connection.
Eventually: your diagnosis (pathology report or oncologist letter), records of treatment (surgeries, chemotherapy, radiation), and as much detail as you can recall about which relaxer products you used and for how long. You do not need all of this to start. The attorney's intake team gathers most of it under HIPAA authorization.
Very common, and not disqualifying. Most plaintiffs document use through a sworn declaration covering brand recall, salon name, year ranges, and where they bought the products. Receipts are helpful but not required.
That is the typical case profile. You list every brand and product you can recall using; the attorney's team helps reconstruct the timeline. Multiple-brand use does not weaken the claim. It usually strengthens it because of the longer cumulative exposure.
California claims are not intaked through this page because California has separate handling (a different attorney network and specific consent rules). California residents with a covered diagnosis should still seek legal counsel directly; we do not route through this page to avoid conflicts.
A bellwether is a representative test case chosen from the MDL to be tried first. Outcomes (verdicts or settlements) inform the value of the remaining cases. MDL 3060 bellwether selection is in progress; the first trials are anticipated 2026 to 2027.
Tiered settlement frameworks are typical in mass torts. Tiers are based on diagnosis severity, treatment received, and exposure duration. The compensation table above shows current pre-bellwether projections; final tiers are set by master settlement negotiations after the bellwether outcomes.
A multidistrict litigation (MDL) is a federal court tool that consolidates many similar cases under one judge for pretrial proceedings. MDL 3060 is the consolidation of hair-relaxer cancer cases in the Northern District of Illinois, before Judge Mary M. Rowland. Each plaintiff's case remains individual, but discovery, motions, and bellwether trials are coordinated by Judge Rowland.
Nothing. We get paid by the law firms or affiliate fees from the court-appointed administrator. You pay zero up front and zero out of any payout you receive.
Only if you check the consent box. We give you the choice. If you do not consent, your claim is captured and we route it to the administrator directly without sharing your phone number.
Yes, always. If we route your claim to a law firm, you can choose to file directly with the same firm or pick a different one. We exist because most people throw the notice letter away. We make it not happen.
No. We are not a law firm and do not provide legal advice. We are a platform that captures your claim, qualifies it, and routes it to the court-appointed administrator or a law firm of your choice.